Clesrovimab

Tax included
Clesrovimab (MK1654) is a fully human, anti-RSV fusion (RSV F) glycoprotein monoclonal antibody. Clesrovimab has the potential for the research of respiratory syncytial virus infection.
MedChemExpress 
HY-P99804

Data sheet

Size
Multiple sizes
Reactivity
RSV
CAS
2429913-18-6